Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.
RELATED CONTENT
January 4, 2013 — Among oncology software products, customers ranked Elekta first for its MOSAIQ Oncology Information System (OIS) in a survey by KLAS, an independent research firm.
January 04, 2013 
December 28, 2012 — Elekta announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Clarity 4D Monitoring software. Physicians will now be able to monitor the motion of the prostate and surrounding tissues and organs – in real-time and with sub-millimeter accuracy – during the delivery of therapeutic radiation beams.
December 28, 2012 
December 14, 2012 — KLAS has released the 2012 Best in KLAS Awards: Software and Services report ranking the best performing healthcare IT vendors in just under 100 market segments. This year, nearly 20,000 provider interviews led to a mix of newly crowned and repeat Best in KLAS winners.
December 14, 2012 At the 54th Annual Meeting of the American Society for Radiation Oncology (ASTRO, Boston, Mass.), Elekta announced that MOSAIQ Oncology Information System (OIS) v 2.50 now includes connectivity with Nucletron's microSelectron® Digital afterloader. This added connectivity allows the treatment record and chart information, in addition to dose and structure sets, to be part of the complete patient record – saving time, simplifying workflow and creating a paperless flow of brachytherapy practice information.
November 05, 2012 
November 2, 2012 — Elekta and Philips Healthcare announced they will expand a joint program to develop an imaging treatment platform that merges radiation therapy and magnetic resonance imaging (MRI) technology in a single treatment system.
November 02, 2012 October 30, 2012 — Civco Medical Solutions announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Protura robotic patient positioning system integration with the AlignRT 3-D imaging system. The FDA also granted approval to integrate the system with Elekta's motion management interface.
October 30, 2012 
The ability of magnetic resonance imaging (MRI) to create exquisite images of the body’s soft tissues – and the tumors that arise amid them – is helping physicians at the National Cancer Center Singapore (NCCS) to precisely shape brachytherapy doses to cervical tumors, while at the same time avoiding exposure to critical healthy organs and tissues.
October 25, 2012 
October 10, 2012 — At the opening of the 2012 Congress of Neurological Surgeons (CNS) annual meeting in Chicago, Elekta and Brainlab announced a collaboration that will enable neurosurgeons and radiation oncologists to use Brainlab's iPlan software together with Elekta's Leksell GammaPlan treatment planning for Gamma Knife radiosurgery.
October 10, 2012 
October 4, 2012 — Less than three months after beginning clinical use of their Elekta Agility 160-leaf multi-leaf collimator (MLC), physicians at The James Cook University Hospital in Middlesbrough, England, have achieved another benchmark – their first use of Agility to deliver radiation therapy employing Elekta's volumetric modulated arc therapy (VMAT).
October 04, 2012 
September 28, 2012 — On Sept. 3, three patients became Gleneagles Hospital's first to receive their radiation therapy treatments on the center's new Elekta Synergy treatment system equipped with Agility 160-leaf multi-leaf collimator (MLC).
September 28, 2012